FDA Inspection 971471 — Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Gedian Humanwell Pharmaceutical Co., Ltd. on May 13, 2016 in Ezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 13, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)